82 related articles for article (PubMed ID: 14709626)
21. In vivo chronic exposure to heroin or naltrexone selectively inhibits liver microsome formation of estradiol-3-glucuronide in the rat.
Antonilli L; Brusadin V; Milella MS; Sobrero F; Badiani A; Nencini P
Biochem Pharmacol; 2008 Sep; 76(5):672-9. PubMed ID: 18639530
[TBL] [Abstract][Full Text] [Related]
22. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.
Wen Z; Tallman MN; Ali SY; Smith PC
Drug Metab Dispos; 2007 Mar; 35(3):371-80. PubMed ID: 17151191
[TBL] [Abstract][Full Text] [Related]
23. Glucuronidation of thyroxine in human liver, jejunum, and kidney microsomes.
Yamanaka H; Nakajima M; Katoh M; Yokoi T
Drug Metab Dispos; 2007 Sep; 35(9):1642-8. PubMed ID: 17591679
[TBL] [Abstract][Full Text] [Related]
24. Glucuronidation of diflunisal, (-)-morphine, 4-nitrophenol, and propofol in liver microsomes of two patients with Crigler-Najjar syndrome type I.
Brunelle FM; Raoof AA; de ville de Goyet J; Verbeeck RK
Biopharm Drug Dispos; 1996 May; 17(4):311-7. PubMed ID: 8743402
[TBL] [Abstract][Full Text] [Related]
25. Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A6 enzymes.
Hanioka N; Takeda Y; Jinno H; Tanaka-Kagawa T; Naito S; Koeda A; Shimizu T; Nomura M; Narimatsu S
Chem Biol Interact; 2006 Dec; 164(1-2):136-45. PubMed ID: 17027947
[TBL] [Abstract][Full Text] [Related]
26. Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia.
Chang JC; Lu R; Lin C; Xu SM; Kan YW; Porcu S; Carlson E; Kitamura M; Yang S; Flebbe-Rehwaldt L; Gaensler KM
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14886-90. PubMed ID: 9843985
[TBL] [Abstract][Full Text] [Related]
27. In vitro glucuronidation kinetics of deoxynivalenol by human and animal microsomes and recombinant human UGT enzymes.
Maul R; Warth B; Schebb NH; Krska R; Koch M; Sulyok M
Arch Toxicol; 2015 Jun; 89(6):949-60. PubMed ID: 24927789
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of ebracteolata compound B studied in vitro with human liver microsomes, HepG2 cells, and recombinant human enzymes.
Zhang X; Yao Y; Lou Y; Jiang H; Wang X; Chai X; Zeng S
Drug Metab Dispos; 2010 Dec; 38(12):2157-65. PubMed ID: 20837661
[TBL] [Abstract][Full Text] [Related]
29. Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds.
King CD; Rios GR; Green MD; MacKenzie PI; Tephly TR
Drug Metab Dispos; 1997 Feb; 25(2):251-5. PubMed ID: 9029056
[TBL] [Abstract][Full Text] [Related]
30. N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferases.
Yan Z; Caldwell GW; Gauthier D; Leo GC; Mei J; Ho CY; Jones WJ; Masucci JA; Tuman RW; Galemmo RA; Johnson DL
Drug Metab Dispos; 2006 May; 34(5):748-55. PubMed ID: 16455802
[TBL] [Abstract][Full Text] [Related]
31. Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver.
Mano Y; Usui T; Kamimura H
Pharm Res; 2006 Jul; 23(7):1502-8. PubMed ID: 16783480
[TBL] [Abstract][Full Text] [Related]
32. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
Hanioka N; Naito T; Narimatsu S
Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
[TBL] [Abstract][Full Text] [Related]
33. Characterization of 2-[[4-[[2-(1H-tetrazol-5-ylmethyl)phenyl]methoxy]methyl]quinoline N-glucuronidation by in vitro and in vivo approaches.
Stevens JC; Fayer JL; Cassidy KC
Drug Metab Dispos; 2001 Mar; 29(3):289-95. PubMed ID: 11181497
[TBL] [Abstract][Full Text] [Related]
34. Hepatic microsomal UDP-glucuronosyltransferase (UGT) activities in the microminipig.
Higashi E; Ando A; Iwano S; Murayama N; Yamazaki H; Miyamoto Y
Biopharm Drug Dispos; 2014 Sep; 35(6):313-20. PubMed ID: 24752421
[TBL] [Abstract][Full Text] [Related]
35. Metabolic stability and determination of cytochrome P450 isoenzymes' contribution to the metabolism of medetomidine in dog liver microsomes.
Duhamel MC; Troncy E; Beaudry F
Biomed Chromatogr; 2010 Aug; 24(8):868-77. PubMed ID: 20020418
[TBL] [Abstract][Full Text] [Related]
36. Determination of species-difference in microsomal metabolism of amitriptyline using a predictive MRM-IDA-EPI method.
Lee JY; Lee SY; Lee K; Oh SJ; Kim SK
Chem Biol Interact; 2015 Mar; 229():109-18. PubMed ID: 25623954
[TBL] [Abstract][Full Text] [Related]
37. Structural requirements in the reaction of morphine uridine diphosphate glucuronyltransferase with opioid substances.
Sanchez E; Del Villar E; Tephly TR
Biochem J; 1978 Jan; 169(1):173-7. PubMed ID: 415737
[TBL] [Abstract][Full Text] [Related]
38. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
Amato G; Longo V; Mazzaccaro A; Gervasi PG
Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
[TBL] [Abstract][Full Text] [Related]
39. Sulfinpyrazone C-glucuronidation is catalyzed selectively by human UDP-glucuronosyltransferase 1A9.
Kerdpin O; Elliot DJ; Mackenzie PI; Miners JO
Drug Metab Dispos; 2006 Dec; 34(12):1950-3. PubMed ID: 16985098
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
